Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
Focus on Patient Care Brings Industry Together to Fight Crisis
09:01pm, Tuesday, 31'st Mar 2020
Fresenius Medical Care North America (FMCNA) and DaVita Inc. (DVA) today announced a collaboration in response to Novel Coronavirus (COVID-19), which aims to support the broader kidney care community
How to Find the Best Stocks in a Bear Market
08:55pm, Tuesday, 31'st Mar 2020
Sometimes a good stock can go bad and vice versa. Here's a simple way to keep up on the latest upgrades and downgrades.
CytoSorb Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care
11:08am, Tuesday, 31'st Mar 2020
CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-
Edited Transcript of CRMD earnings conference call or presentation 16-Mar-20 8:30pm GMT
10:44am, Monday, 30'th Mar 2020
Q4 2019 CorMedix Inc Earnings Call
Fresenius SE & Co KGaA (FRA:FRE) Given a €37.50 Price Target at Sanford C. Bernstein
08:28am, Monday, 30'th Mar 2020
Fresenius SE & Co KGaA (FRA:FRE) has been given a €37.50 ($43.60) price objective by analysts at Sanford C. Bernstein in a research report issued on Monday, Borsen Zeitung reports. The brokerage pre
Edited Transcript of CTSO.OQ earnings conference call or presentation 5-Mar-20 9:45pm GMT
01:52am, Saturday, 28'th Mar 2020
Full Year 2019 Cytosorbents Corp Earnings Call
Edited Transcript of AKBA earnings conference call or presentation 10-Mar-20 1:00pm GMT
10:36pm, Thursday, 26'th Mar 2020
Q4 2019 Akebia Therapeutics Inc Earnings Call
Fresenius SE & Co KGaA (FRA:FRE) PT Set at €59.50 by Berenberg Bank
09:14am, Thursday, 26'th Mar 2020
Fresenius SE & Co KGaA (FRA:FRE) has been assigned a €59.50 ($69.19) price target by analysts at Berenberg Bank in a research report issued to clients and investors on Thursday, Borsen Zeitung repor
Fresenius SE & Co KGaA (FRA:FRE) Earns "Neutral" Rating from UBS Group
07:18am, Thursday, 26'th Mar 2020
UBS Group reiterated their neutral rating on shares of Fresenius SE & Co KGaA (FRA:FRE) in a report issued on Monday morning, Borsen Zeitung reports. A number of other equities research analysts also
Fresenius SE & Co KGaA (FRA:FRE) Rating Reiterated by DZ Bank
08:46am, Wednesday, 25'th Mar 2020
Fresenius SE & Co KGaA (FRA:FRE)‘s stock had its “buy” rating reiterated by research analysts at DZ Bank in a report released on Monday, Borsen Zeitung reports. A number of other research analys
Imagine Owning Fresenius Medical Care KGaA (ETR:FME) And Wondering If The 27% Share Price Slide Is Justified
05:29am, Monday, 23'rd Mar 2020
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. By comparison...
Fresenius SE & Co KGaA (FRA:FRE) PT Set at €62.00 by Kepler Capital Markets
08:12am, Sunday, 22'nd Mar 2020
Fresenius SE & Co KGaA (FRA:FRE) has been assigned a €62.00 ($72.09) price objective by equities researchers at Kepler Capital Markets in a research report issued to clients and investors on Friday,
Edited Transcript of CARA earnings conference call or presentation 27-Feb-20 9:30pm GMT
04:44pm, Friday, 20'th Mar 2020
Q4 2019 Cara Therapeutics Inc Earnings Call
